Fennec Pharmaceuticals

(NASDAQ) FENC

Current Price$11.13

Market Cap$382.80M

Since IPO (2004)-90%

5 Year+49%

1 Year+33%

1 Month+11%

Fennec Pharmaceuticals Financials at a Glance

Market Cap

$382.80M

Revenue (TTM)

$51.00M

Net Income (TTM)

-$8.38M

EPS (TTM)

-$0.30

P/E Ratio

-37.20

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Price

$11.13

Volume

2,258

Open

$11.18

Price

$11.13

Volume

2,258

Open

$11.18

Previous Close

$11.02

Daily Range

$10.86 - $11.23

52-Week Range

$5.65 - $11.23

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Price

$11.13

Volume

2,258

Open

$11.18

Previous Close

$11.02

Daily Range

$10.86 - $11.23

52-Week Range

$5.65 - $11.23

Estimated Earnings Date

Aug 13, 2026

FENC News

Fennec Q2 Sales Jump 33 Percent

Motley Fool Markets TeamAug 14, 2025

FENC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fennec Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jeffrey S Hackman

Website

www.fennecpharma.com

Headquarters

Research Triangle Park, NC 27709, US

FENC Financials

Key Financial Metrics (TTM)

Gross Margin

92.23%

Operating Margin

-11.04%

Net Income Margin

-16.42%

Return on Equity

-54.75%

Return on Capital

-18.10%

Return on Assets

-11.66%

Earnings Yield

-2.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$382.80M

Shares Outstanding

34.74M

Volume

2.26K

Avg. Volume

267.96K

Financials (TTM)

Gross Profit

$47.04M

Operating Income

-$5.63M

EBITDA

-$6.67M

Operating Cash Flow

-$5.78M

Capital Expenditure

$0.00

Free Cash Flow

-$5.78M

Cash & ST Invst.

$40.18M

Total Debt

$0.00

Fennec Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$15.11M

+72.6%

Gross Profit

$14.54M

+73.5%

Gross Margin

96.23%

N/A

Market Cap

$382.80M

N/A

Market Cap/Employee

$11.96M

N/A

Employees

N/A

Net Income

$201.00K

+117.3%

EBITDA

$234.00K

+142.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$40.18M

+77.2%

Total Debt

$0.00

-100.0%

Accounts Receivable

$18.76M

+21.5%

Inventory

$1.86M

+32.2%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

N/A

Return on Assets

-11.66%

N/A

Return on Invested Capital

-9.05%

N/A

Free Cash Flow

$2.38M

+155.1%

Operating Cash Flow

$2.38M

+155.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ENTAEnanta Pharmaceuticals, Inc.

ENTAEnanta Pharmaceuticals, Inc.$14.23+1.65%

RNACCartesian Therapeutics, Inc.

RNACCartesian Therapeutics, Inc.$9.38-0.42%

OBIOOrchestra BioMed Holdings, Inc.

OBIOOrchestra BioMed Holdings, Inc.$4.49+5.78%

PRLDPrelude Therapeutics Incorporated

PRLDPrelude Therapeutics Incorporated$4.69+6.98%

NAUTNautilus Biotechnolgy, Inc.

NAUTNautilus Biotechnolgy, Inc.$1.82-9.25%

EPRXEupraxia Pharmaceuticals Inc.

EPRXEupraxia Pharmaceuticals Inc.$6.62+0.30%

AVTXAvalo Therapeutics, Inc.

AVTXAvalo Therapeutics, Inc.$19.33+6.21%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CMCSAComcast

CMCSAComcast$24.65+0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.59-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.35+0.15%

UPCUniverse Pharmaceuticals Inc

UPCUniverse Pharmaceuticals Inc$11.40+2.85%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.53-0.03%

MARAMara Holdings

MARAMara Holdings$14.37-0.01%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.84-0.03%

Questions About FENC

What is the current price of Fennec Pharmaceuticals?

Fennec Pharmaceuticals is trading at $11.13 per share.

What is the 52-week range for Fennec Pharmaceuticals?

Over the past 52 weeks, Fennec Pharmaceuticals has traded between $5.65 and $11.23.

How much debt does Fennec Pharmaceuticals have?

As of the most recent reporting period, Fennec Pharmaceuticals reported total debt of $0.00.

How much cash does Fennec Pharmaceuticals have on hand?

Fennec Pharmaceuticals reported $40.18M in cash and cash equivalents in its most recent financial results.

What is Fennec Pharmaceuticals’s dividend yield?

Fennec Pharmaceuticals does not currently have a dividend yield.

Fennec Pharmaceuticals

Fennec Pharmaceuticals Financials at a Glance

FENC News

Fennec Q2 Sales Jump 33 Percent

FENC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Fennec Pharmaceuticals

FENC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Fennec Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FENC

What is the current price of Fennec Pharmaceuticals?

What is the 52-week range for Fennec Pharmaceuticals?

How much debt does Fennec Pharmaceuticals have?

How much cash does Fennec Pharmaceuticals have on hand?

What is Fennec Pharmaceuticals’s dividend yield?

Premium Investing Services